T-cell rich B-cell lymphoma masquerading as Hodgkin disease: excellent outcome to inadequate therapy
Bol. Asoc. Méd. P. R
; Bol. Asoc. Méd. P. R;88(4/6): 32-34, Apr.-Jun. 1996.
Article
em En
| LILACS
| ID: lil-411533
Biblioteca responsável:
BR1.1
RESUMO
T-cell rich B-cell lymphomas (TCRBCL) are characterized as non-Hodgkin lymphomas with a minor population of malignant B-cells scattered among predominant, reactive T-lymphocytes. This entity can easily be confused with lymphocyte-predominant Hodgkin disease (HD-LP), resulting in inappropriate therapy and a poor outcome. Because of their similarity, the pathology of patients treated for HD-LP with an inadequate or short-lived response to therapy should always be reviewed by an expert hematopathologist. We describe the first reported patient in Puerto Rico with TCRBCL, originally diagnosed and treated as HD-LP. Although the patient received partial, substandard therapy for TCRBCL, an excellent prolonged complete response ensued, thus, giving further credence to the fact that malignant lymphomas and TCRBCL in particular, are a protean group of disorders which should be precisely and accurately classified before the proper therapeutic strategies can be outlined
Buscar no Google
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Doença de Hodgkin
/
Linfoma de Células B
Tipo de estudo:
Diagnostic_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Bol. Asoc. Méd. P. R
Assunto da revista:
MEDICINA
Ano de publicação:
1996
Tipo de documento:
Article
País de afiliação:
Porto Rico
País de publicação:
Porto Rico